Thai billionaire planning USD500 million IPO for F&N

Thai billionaire Charoen Sirivadhanabhakdi eyes USD500 million IPO for F&N REIT. Charoen Sirivadhanabhakdi, Thai tycoon and the country's third richest man, announced plans of an IPO for Fraser and Neave (F&N) REIT.


ING’s Asia divestment plan nearing conclusion

MBK agrees to buy ING's South Korean unit to bring the latter's Asia exit plan closer to conclusion.

Axiata Group planning IPO of assets

Malaysia's largest mobile phone operator has planned an IPO of its telecommunications tower assets.

Risk-weight study shows high-profile banks barely cover capital cost

A Bain & Co. study showed Swedish banks outperform peers, but Europe's financial sector poised to catch up.


Latest News

NY State Attorney General files lawsuit against Trump investment school for operating without a license.
Amgen acquires Onyx Pharmaceuticals for $10.4 billion. Declining sales of its flagship product pushed Amgen to a $10. 4 billion purchase of Onyx Pharmaceuticals, concluding the two-month-long auction of Onyx.
Top Chinese banks had been expecting to win approval for negotiable certificates of deposit worth CNY10 billion.
The State Bank of India announced that it had expected to receive a total of INR4 billion in recapitalization from the government.
There were more than 110 China brokerages that would undergo government probe after Everbright Securities made a CNY23.4 billion buy order error.
Reliance Life announced to sell a 5% stake to private, public and cooperative banks. Reliance Life, a private insurer operating in India, said that it had planned to explore distribution tie-ups with a number of banks.
ONGC announced an acquisition deal for a 10% stake in Anadarko Corp priced USD2.6 billion. ONGC Videsh Ltd (OVL) had announced its planned acquisition of a 10% stake at Anadarko Corp.
Air India Express had announced it was looking at domestic expansion to be able to compete with three current budget airlines dominating India by the end of the year.
Markit, a financial data company, said that the US factory activities increased by 53.9% which was its best rise since March.
Amgen Inc. might announced the agreement to acquire Onyx Pharmaceuticals Inc. for USD 125 per share piece as soon as Monday.